JP2005532351A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005532351A5 JP2005532351A5 JP2004510706A JP2004510706A JP2005532351A5 JP 2005532351 A5 JP2005532351 A5 JP 2005532351A5 JP 2004510706 A JP2004510706 A JP 2004510706A JP 2004510706 A JP2004510706 A JP 2004510706A JP 2005532351 A5 JP2005532351 A5 JP 2005532351A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- use according
- pharmaceutical composition
- cancer
- carbon monoxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 33
- 206010028980 Neoplasm Diseases 0.000 claims 22
- 201000011510 cancer Diseases 0.000 claims 22
- 239000007789 gas Substances 0.000 claims 18
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 claims 15
- 229910002091 carbon monoxide Inorganic materials 0.000 claims 15
- 230000033115 angiogenesis Effects 0.000 claims 10
- 239000000203 mixture Substances 0.000 claims 10
- 210000000056 organ Anatomy 0.000 claims 8
- 210000004072 lung Anatomy 0.000 claims 6
- 210000003800 pharynx Anatomy 0.000 claims 6
- 238000002512 chemotherapy Methods 0.000 claims 5
- 238000001959 radiotherapy Methods 0.000 claims 5
- 210000001519 tissue Anatomy 0.000 claims 5
- 241000283984 Rodentia Species 0.000 claims 4
- 239000007788 liquid Substances 0.000 claims 4
- 238000001356 surgical procedure Methods 0.000 claims 4
- 208000024891 symptom Diseases 0.000 claims 4
- 238000011200 topical administration Methods 0.000 claims 4
- 210000000133 brain stem Anatomy 0.000 claims 3
- 210000000481 breast Anatomy 0.000 claims 3
- 210000003169 central nervous system Anatomy 0.000 claims 3
- 210000003679 cervix uteri Anatomy 0.000 claims 3
- 210000001072 colon Anatomy 0.000 claims 3
- 210000003238 esophagus Anatomy 0.000 claims 3
- 210000003128 head Anatomy 0.000 claims 3
- 210000003734 kidney Anatomy 0.000 claims 3
- 210000000867 larynx Anatomy 0.000 claims 3
- 210000004185 liver Anatomy 0.000 claims 3
- 210000004379 membrane Anatomy 0.000 claims 3
- 239000012528 membrane Substances 0.000 claims 3
- 210000000214 mouth Anatomy 0.000 claims 3
- 210000003739 neck Anatomy 0.000 claims 3
- 210000001672 ovary Anatomy 0.000 claims 3
- 210000000496 pancreas Anatomy 0.000 claims 3
- 210000003200 peritoneal cavity Anatomy 0.000 claims 3
- 210000002307 prostate Anatomy 0.000 claims 3
- 210000000664 rectum Anatomy 0.000 claims 3
- 210000003491 skin Anatomy 0.000 claims 3
- 210000002784 stomach Anatomy 0.000 claims 3
- 210000001550 testis Anatomy 0.000 claims 3
- 210000003932 urinary bladder Anatomy 0.000 claims 3
- 210000000988 bone and bone Anatomy 0.000 claims 2
- 208000003120 Angiofibroma Diseases 0.000 claims 1
- 206010012689 Diabetic retinopathy Diseases 0.000 claims 1
- 208000010412 Glaucoma Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 206010038933 Retinopathy of prematurity Diseases 0.000 claims 1
- 208000013058 Weber syndrome Diseases 0.000 claims 1
- 210000000683 abdominal cavity Anatomy 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 201000007293 brain stem infarction Diseases 0.000 claims 1
- 206010025135 lupus erythematosus Diseases 0.000 claims 1
- 208000002780 macular degeneration Diseases 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 230000002107 myocardial effect Effects 0.000 claims 1
- 201000003142 neovascular glaucoma Diseases 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 230000002093 peripheral effect Effects 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
- 230000024883 vasodilation Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38656102P | 2002-06-05 | 2002-06-05 | |
| PCT/US2003/017731 WO2003103585A2 (en) | 2002-06-05 | 2003-06-05 | Methods of treating angiogenesis, tumor growth, and metastasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005532351A JP2005532351A (ja) | 2005-10-27 |
| JP2005532351A5 true JP2005532351A5 (https=) | 2006-06-08 |
Family
ID=29736179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004510706A Pending JP2005532351A (ja) | 2002-06-05 | 2003-06-05 | 血管形成、腫瘍増殖、および転移を治療する方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20040258772A1 (https=) |
| EP (1) | EP1509237A4 (https=) |
| JP (1) | JP2005532351A (https=) |
| CN (1) | CN1674922A (https=) |
| AU (1) | AU2003248621A1 (https=) |
| CA (1) | CA2487413A1 (https=) |
| EA (1) | EA200401622A1 (https=) |
| HR (1) | HRP20041146A2 (https=) |
| MX (1) | MXPA04012167A (https=) |
| NO (1) | NO20045354L (https=) |
| PL (1) | PL374375A1 (https=) |
| RS (1) | RS105304A (https=) |
| UA (1) | UA87438C2 (https=) |
| WO (1) | WO2003103585A2 (https=) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7678390B2 (en) | 1999-04-01 | 2010-03-16 | Yale University | Carbon monoxide as a biomarker and therapeutic agent |
| GB0111872D0 (en) | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
| MXPA03012031A (es) * | 2001-06-21 | 2005-07-01 | Univ Yale | El monoxido de carbono mejoraresultados en transplantes de tejido y organo y suprime apoptosis. |
| NZ534912A (en) * | 2002-02-04 | 2007-08-31 | Alfama Investigacao E Desenvol | supramolecule aggregate comprising CO containing organometallic or transition metal complex and anti-inflammatory agent or biphosphonate phosphonate derivative |
| US20080026984A1 (en) * | 2002-02-04 | 2008-01-31 | Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
| US7968605B2 (en) * | 2002-02-04 | 2011-06-28 | ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
| RS91004A (sr) | 2002-04-15 | 2007-02-05 | University Of Pittsburgh Of The Commonwealth System Of Higher Education, | Postupci za lečenje ileusa |
| EP1499328B1 (en) | 2002-04-15 | 2015-09-16 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Methods of treating necrotizing enterocolitis |
| WO2003088748A1 (en) | 2002-04-15 | 2003-10-30 | Beth Israel Deaconess Medical Center | Use of heme oxygenase-1 and products of heme degradation |
| JP4549847B2 (ja) | 2002-05-17 | 2010-09-22 | イエール ユニバーシティ | 肝炎の治療方法 |
| CN1674942A (zh) * | 2002-06-21 | 2005-09-28 | 联邦高等教育系统匹兹堡大学 | 氧化氮、血红素加氧酶－1和血红素降解产物的药学用途 |
| DE10230165A1 (de) * | 2002-07-04 | 2004-01-15 | Ino Therapeutics Gmbh | Verfahren und Vorrichtung zur Administration von Kohlenmonoxid |
| US20100158795A1 (en) * | 2008-06-12 | 2010-06-24 | Pulmonx | Methods and systems for assessing lung function and delivering therapeutic agents |
| PL377733A1 (pl) * | 2002-11-07 | 2006-02-06 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Leczenie wstrząsu krwotocznego |
| GB2395432B (en) * | 2002-11-20 | 2005-09-14 | Northwick Park Inst For Medica | Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
| US20070207217A1 (en) * | 2003-02-03 | 2007-09-06 | Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda | Method for treating a mammal by administration of a compound having the ability to release CO |
| AU2004262976A1 (en) * | 2003-08-04 | 2005-02-17 | Hemocorm Limited | Use of boranocarbonates for the therapeutic delivery of carbon monoxide |
| CN100475275C (zh) * | 2004-01-05 | 2009-04-08 | 董永华 | 肿瘤血管栓塞剂及其储存和释放装置 |
| JPWO2007073005A1 (ja) * | 2005-12-22 | 2009-06-04 | 学校法人慶應義塾 | メチル基転移反応調節物質 |
| GB0601394D0 (en) | 2006-01-24 | 2006-03-01 | Hemocorm Ltd | Therapeutic delivery of carbon monoxide |
| JP5552262B2 (ja) * | 2009-05-13 | 2014-07-16 | フクダ電子株式会社 | 肺疾患の治療に用いられる気体製剤 |
| JP6118731B2 (ja) * | 2011-01-14 | 2017-04-19 | チルドレンズ ホスピタル ロサンゼルス | 鎌状赤血球疾患を含む、疾患の治療のための一酸化炭素の溶液 |
| EP2699242B1 (en) | 2011-04-19 | 2017-11-01 | Alfama, Inc. | Carbon monoxide releasing molecules and uses thereof |
| JP6134710B2 (ja) | 2011-07-21 | 2017-05-24 | アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． | 一酸化ルテニウム放出分子およびその使用 |
| CA2844660A1 (en) | 2011-08-09 | 2013-02-14 | Leo E. Otterbein | Methods of treating dna damage |
| JPWO2018225785A1 (ja) * | 2017-06-06 | 2020-04-16 | 株式会社Ａｔｏｍｉｓ | ワクチン組成物 |
| WO2021105900A1 (en) | 2019-11-25 | 2021-06-03 | Beyond Air, Inc. | System and method for delivery of gas to a tissue |
| WO2022015986A1 (en) * | 2020-07-16 | 2022-01-20 | Cornell University | Methods for treating metastatic cancer using low dose carbon monoxide |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4053590A (en) * | 1975-02-27 | 1977-10-11 | Alza Corporation | Compositions of matter comprising macromolecular hemoglobin |
| US4264739A (en) * | 1979-01-05 | 1981-04-28 | Merck & Co., Inc. | Sparger for cell culture system |
| US5240912A (en) * | 1983-05-09 | 1993-08-31 | Todaro George J | Transforming growth factor (TGF) peptides |
| US5084380A (en) * | 1985-01-29 | 1992-01-28 | Applied Biotechnology | Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins |
| US5449665A (en) * | 1985-09-24 | 1995-09-12 | Item Development Aktiebolag | Continuous intravenous infusion of adenosine to human patients undergoing percutaneous transluminal angioplasty |
| DE3739650C1 (de) * | 1987-11-23 | 1989-05-24 | Immuno Ag | Fermenter zum Zuechten von Zellkulturen |
| US5180366A (en) * | 1990-10-10 | 1993-01-19 | Woods W T | Apparatus and method for angioplasty and for preventing re-stenosis |
| US5792325A (en) * | 1990-11-15 | 1998-08-11 | Richardson, Jr.; William H. | Electric arc material processing system |
| US5293875A (en) * | 1992-06-16 | 1994-03-15 | Natus Medical Incorporated | In-vivo measurement of end-tidal carbon monoxide concentration apparatus and methods |
| NZ262679A (en) * | 1993-02-22 | 1997-08-22 | Vivorx Pharmaceuticals Inc | Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell |
| US5763431A (en) * | 1993-08-20 | 1998-06-09 | Jackson; Meyer B. | Method for regulating neuropeptide hormone secretion |
| DE4421433C1 (de) * | 1994-06-18 | 1995-06-08 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit Wirkstoffen, die Kohlenmonoxid-Quellen darstellen, Verfahren zu seiner Herstellung und seine Verwendung |
| US5476764A (en) * | 1994-09-16 | 1995-12-19 | The Regents Of The University Of California | Method using CO for extending the useful shelf-life of refrigerated red blood cells |
| US6066333A (en) * | 1994-09-22 | 2000-05-23 | William Harvey Research Limited | Pharmaceutical control of inflammation |
| US5664563A (en) * | 1994-12-09 | 1997-09-09 | Cardiopulmonary Corporation | Pneumatic system |
| US5914316A (en) * | 1994-12-16 | 1999-06-22 | Washington University | Method of inhibiting intimal hyperplasia |
| US5712293A (en) * | 1995-06-07 | 1998-01-27 | Sepracor, Inc. | Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride |
| FR2735382B1 (fr) * | 1995-06-15 | 1997-07-25 | Air Liquide | Installation de production de monoxyde de carbone incorporant une unite de separation cryogenique |
| JP3195363B2 (ja) * | 1995-06-30 | 2001-08-06 | ザイモジェネティクス，インコーポレイティド | Ｐｄｇｆアンタゴニストとしての４−〔２−（ｎ−２−カルボキサミドインドール）アミノエチル〕ベンゼンスルホンアミドまたはスルホニル尿素 |
| ES2267141T3 (es) * | 1996-04-05 | 2007-03-01 | The General Hospital Corporation | Tratamiento de una hemoglobinopatia. |
| US6069132A (en) * | 1996-08-14 | 2000-05-30 | Revanker; Ganapathi R. | Phosphazole compounds |
| US6316403B1 (en) * | 1996-09-27 | 2001-11-13 | The Trustees Of Columbia University In The City Of New York | Methods for treating an ischemic disorder and improving stroke outcome |
| US8128963B2 (en) * | 1996-09-27 | 2012-03-06 | The Trustees Of Columbia University In The City Of New York | Methods for treating ischemic disorders using carbon monoxide |
| TR200101502T2 (tr) * | 1998-03-16 | 2002-06-21 | Celgene Corporation | 2-(2,6-dioksopiperidin-3-il) izoindolin türevleri, bunların hazırlanması ve enflamatuar sitokinlerin inhibitörleri olarak kullanımı |
| US6203991B1 (en) * | 1998-08-21 | 2001-03-20 | The Regents Of The University Of Michigan | Inhibition of smooth muscle cell migration by heme oxygenase I |
| US7678390B2 (en) * | 1999-04-01 | 2010-03-16 | Yale University | Carbon monoxide as a biomarker and therapeutic agent |
| US20050250688A1 (en) * | 1999-04-01 | 2005-11-10 | The Trustees Of Columbia University In The City Of New York | Methods for treating an ischemic disorder and improving stroke outcome |
| US7632803B2 (en) * | 1999-10-01 | 2009-12-15 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
| BR0208012A (pt) * | 2001-03-20 | 2004-03-02 | Glaxo Group Ltd | Usos de pelo menos duas drogas e um propelente hfa e de pelo menos uma composição farmaceêutica, e, inalador acondicionado para tratar asma |
| US20030068387A1 (en) * | 2001-03-30 | 2003-04-10 | Roland Buelow | Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders |
| GB0111872D0 (en) * | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
| EP1395241B9 (en) * | 2001-05-25 | 2005-06-15 | Medtronic, Inc. | Implantable medical device with controllable gaseous agent release system |
| MXPA03012031A (es) * | 2001-06-21 | 2005-07-01 | Univ Yale | El monoxido de carbono mejoraresultados en transplantes de tejido y organo y suprime apoptosis. |
| US7069026B2 (en) * | 2001-06-28 | 2006-06-27 | Nokia Corporation | Geographic area assisted system selection for mobile stations |
| NZ534912A (en) * | 2002-02-04 | 2007-08-31 | Alfama Investigacao E Desenvol | supramolecule aggregate comprising CO containing organometallic or transition metal complex and anti-inflammatory agent or biphosphonate phosphonate derivative |
| BRPI0307673A2 (pt) * | 2002-02-13 | 2016-11-08 | Beth Israel Hospital | métodos de tratar doença vascular. |
| RS91004A (sr) * | 2002-04-15 | 2007-02-05 | University Of Pittsburgh Of The Commonwealth System Of Higher Education, | Postupci za lečenje ileusa |
| EP1499328B1 (en) * | 2002-04-15 | 2015-09-16 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Methods of treating necrotizing enterocolitis |
| JP4549847B2 (ja) * | 2002-05-17 | 2010-09-22 | イエール ユニバーシティ | 肝炎の治療方法 |
| CN1674942A (zh) * | 2002-06-21 | 2005-09-28 | 联邦高等教育系统匹兹堡大学 | 氧化氮、血红素加氧酶－1和血红素降解产物的药学用途 |
| PL377733A1 (pl) * | 2002-11-07 | 2006-02-06 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Leczenie wstrząsu krwotocznego |
-
2003
- 2003-06-05 UA UAA200500061A patent/UA87438C2/ru unknown
- 2003-06-05 CN CNA038188724A patent/CN1674922A/zh active Pending
- 2003-06-05 MX MXPA04012167A patent/MXPA04012167A/es not_active Application Discontinuation
- 2003-06-05 EP EP03757348A patent/EP1509237A4/en not_active Withdrawn
- 2003-06-05 HR HR20041146A patent/HRP20041146A2/xx not_active Application Discontinuation
- 2003-06-05 PL PL03374375A patent/PL374375A1/xx not_active Application Discontinuation
- 2003-06-05 WO PCT/US2003/017731 patent/WO2003103585A2/en not_active Ceased
- 2003-06-05 US US10/455,564 patent/US20040258772A1/en not_active Abandoned
- 2003-06-05 EA EA200401622A patent/EA200401622A1/ru unknown
- 2003-06-05 AU AU2003248621A patent/AU2003248621A1/en not_active Abandoned
- 2003-06-05 RS YUP-1053/04A patent/RS105304A/sr unknown
- 2003-06-05 CA CA002487413A patent/CA2487413A1/en not_active Abandoned
- 2003-06-05 JP JP2004510706A patent/JP2005532351A/ja active Pending
-
2004
- 2004-12-07 NO NO20045354A patent/NO20045354L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005532351A5 (https=) | ||
| JP2579262B2 (ja) | 麻酔方法 | |
| ES2554108T3 (es) | Métodos de tratamiento de la enterocolitis necrosante | |
| JP2005533021A5 (https=) | ||
| CN110724203A (zh) | 一种促进tfeb核转位的短肽及基于其的线性短肽和其减轻脑缺血损伤的应用 | |
| Brown | The Surgery of oral diseases and malformations | |
| Jones et al. | Surgical repair of cleft palate in the horse | |
| Bingham | The early history of neurosurgical anesthesia | |
| JP2017081862A (ja) | 摘出手術後の体重減少を軽減するための医薬組成物 | |
| Barach | The treatment of heart failure by continuous oxygen therapy | |
| Bourne et al. | Methylene chloride in anaesthesia | |
| CN112076214B (zh) | 一种血液增氧液体制剂及其制备方法 | |
| Olsen et al. | Preparation of patients for Peroral Endoscopy | |
| Gleich | Thallium acetate poisoning in the treatment of ringworm of the scalp: Report of two cases | |
| RU1822761C (ru) | Способ лечени экзотоксических ком @ | |
| Karshiyev et al. | ANALYSIS OF THE INCIDENCE WITH NEURALOGY OF TRIGEMINAL NERVE | |
| Coleman et al. | Dipipanone hydrochloride as an adjunct to anaesthesia in obstetrics and surgery | |
| Habershon | On the injurious effects of mercury in the treatment of disease | |
| CIGRAND | readily in even slightly acid medium, but require | |
| McMechan | Nitrous Oxide-Oxygen Analgesia and Anaesthesia in Normal Labor and Operative Obstetrics | |
| Schlenker | PURPURA HEMORRHAGICA TREATED WITH NORMAL HORSE SERUM | |
| INMAN | 1180 DOC. 19, 19251 RESPIRATION AND ANAESTHESIA.-EMUDCALJOUANAr | |
| REAM | NITROUS OXID AND OGYGEN IN DENTAL AND MAJOR SURGERY. | |
| HAMILTON | 226 THE BRITISH MEDICAL OVRNAL.[March l, 1873. | |
| Grimshaw | HÆMOPTYSIS FOLLOWING TYPHUS FEVER. |